Inventor · disambiguated record
Wanlong Ma
Also filed as: MA WANLONG
14 granted patents·14 pending applications·35 citations·filing 2009–2025
91Inventor score
Top patents by PatentIndex Score
28 records- 0192US11345964B2BCR-ABL truncation mutationsQUEST DIAGNOSTICS INVEST LLC·Filed 2018·Granted May 31, 2022·3 cites·26 claims
- 0292US10093980B2BCR-ABL truncation mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2016·Granted Oct 9, 2018·4 cites·22 claims
- 0391US10100365B2Compositions and methods for detecting mutations in JAK2 nucleic acidQUEST DIAGNOSTICS INVEST INC·Filed 2016·Granted Oct 16, 2018·3 cites·11 claims
- 0491US9957574B2BCR-ABL1 splice variants and uses thereofQUEST DIAGNOSTICS INVEST INC·Filed 2017·Granted May 1, 2018·4 cites·13 claims
- 0589US10954569B2Compositions and methods for detecting mutations in JAK2 nucleic acidQUEST DIAGNOSTICS INVEST LLC·Filed 2018·Granted Mar 23, 2021·2 cites·11 claims
- 0689US2025138014A1Mpl mutations in jak2 v617f negative patients with myeloproliferative diseaseQUEST DIAGNOSTICS INVEST LLC·Filed 2024·Application pending·0 cites
- 0788US9593378B2BCR-ABL1 splice variants and uses thereofQUEST DIAGNOSTICS INVEST INC·Filed 2013·Granted Mar 14, 2017·5 cites·11 claims
- 0888US8512948B2Compositions and methods for detecting mutations in JAK2 nucleic acidALBITAR MAHER·Filed 2010·Granted Aug 20, 2013·4 cites·9 claims
- 0988US2025361568A1Compositions and methods for detecting mutations in jak2 nucleic acidQUEST DIAGNOSTICS INVEST LLC·Filed 2025·Application pending·0 cites
- 1087US8603740B2BCR-ABL1 splice variants and uses thereofMA WANLONG·Filed 2010·Granted Dec 10, 2013·5 cites·8 claims
- 1185US9488656B2BCR-ABL truncation mutationsALBITAR MAHER·Filed 2010·Granted Nov 8, 2016·4 cites·22 claims
- 1279US8841074B2MPL mutations in JAK2 V617F negative patients with myeloproliferative diseaseMA WANLONG·Filed 2010·Granted Sep 23, 2014·1 cites·17 claims
- 1379US2023058329A1Bcr-abl truncation mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2022·Application pending·0 cites
- 1478US12378609B2Compositions and methods for detecting mutations in JAK2 nucleic acidQUEST DIAGNOSTICS INVEST LLC·Filed 2021·Granted Aug 5, 2025·0 cites·12 claims
- 1575US9733249B2MPL mutations in JAK2 V617F negative patients with myeloproliferative diseaseQUEST DIAGNOSTICS INVEST INC·Filed 2014·Granted Aug 15, 2017·0 cites·11 claims
- 1673US2021011019A1Mpl mutations in jak2 v617f negative patients with myeloproliferative diseaseQUEST DIAGNOSTICS INVEST LLC·Filed 2020·Application pending·0 cites
- 1771US10782299B2MPL mutations in JAK2 V617F negative patients with myeloproliferative diseaseQUEST DIAGNOSTICS INVEST INC·Filed 2017·Granted Sep 22, 2020·0 cites·5 claims
- 1869US11162142B2BCR-ABL1 splice variants and uses thereofQUEST DIAGNOSTICS INVEST INC·Filed 2018·Granted Nov 2, 2021·0 cites·2 claims
- 1966US2014057270A1Compositions and methods for detecting mutations in jak2 nucleic acidQUEST DIAGNOSTICS INVEST INC·Filed 2013·Application pending·0 cites
- 2054US2013288236A1Wt1 mutations for prognosis of myeloproliferative disordersALBITAR MAHER·Filed 2010·Application pending·0 cites
- 2153US2016201141A1Wt1 mutations for prognosis of myeloproliferative disordersQUEST DIAGNOSTICS INVEST INC·Filed 2015·Application pending·0 cites
- 2252US2011269162A1Ubiquitin proteasome system profiling for diagnosis of chronic liver diseaseQUEST DIAGNOSTICS INVEST INC·Filed 2010·Application pending·0 cites
- 2352US2010112571A1Compositions and methods for detecting mutations in jak2 nucleic acidQUEST DIAGNOSTICS INVEST INC·Filed 2009·Application pending·0 cites
- 2452US2011053198A1Ubiquitin proteasome system profiling and the use thereof in clinical applications for proliferative hematological disordersQUEST DIAGNOSTICS INVEST INC·Filed 2009·Application pending·0 cites
- 2550US2011053197A1Ubiquitin proteasome system profiling and the use thereof in clinical applications for cancer diagnosisQUEST DIAGNOSTICS INVEST INC·Filed 2009·Application pending·0 cites
- 2642US2012329049A1Bcr-abl1 splice variants and uses thereofMA WANLONG·Filed 2010·Application pending·0 cites
- 2739US2013295562A1Methods for detecting risk of myelodysplastic syndrome by genotypic analysisMA WANLONG·Filed 2010·Application pending·0 cites
- 2838US2011053199A1Ubiquitin proteasome system profiling and the use thereof in clinical applications for cancer diagnosisQUEST DIAGNOSTICS INVEST INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wanlong Ma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →